Advertisement
New Zealand markets closed
  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     
  • NZD/USD

    0.6012
    +0.0049 (+0.83%)
     
  • NZD/EUR

    0.5579
    +0.0023 (+0.42%)
     
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD

    2,310.10
    +0.50 (+0.02%)
     
  • NASDAQ

    17,890.79
    +349.25 (+1.99%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • Dow Jones

    38,675.68
    +450.02 (+1.18%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • NZD/JPY

    91.9390
    +0.3640 (+0.40%)
     

Global Medical Exoskeleton Market to Reach $5.8 Billion by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Medical Exoskeleton Industry" - https://www.reportlinker.com/p06032149/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Medical Exoskeleton Market to Reach $5.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Medical Exoskeleton estimated at US$955 Million in the year 2022, is projected to reach a revised size of US$5.8 Billion by 2030, growing at aCAGR of 25.2% over the period 2022-2030. Hardware, one of the segments analyzed in the report, is projected to record 22.3% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 28.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $296 Million, While China is Forecast to Grow at 23.5% CAGR

The Medical Exoskeleton market in the U.S. is estimated at US$296 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$914.1 Million by the year 2030 trailing a CAGR of 23.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 22.6% and 21.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 34 Featured)
- Bionik Laboratories Corp
- B-TEMIA Inc.
- Cyberdyne Inc.
- Ekso Bionics Holdings, Inc.
- ExoAtlet
- Gogoa Mobility Robots SL
- Hocoma AG (A Subsidiary of DIH Technologies)
- Parker Hannifin Corp
- ReWalk Robotics Ltd
- Rex Bionics Ltd.
- Tyromotion GmbH
- US Bionics
- Wearable Robotics SRL


Read the full report: https://www.reportlinker.com/p06032149/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Medical Exoskeleton - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Medical Exoskeleton by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 2: World Historic Review for Medical Exoskeleton by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Medical Exoskeleton by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Hardware by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 5: World Historic Review for Hardware by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2021 and % CAGR

Table 6: World 18-Year Perspective for Hardware by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Software by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 8: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2021 and % CAGR

Table 9: World 18-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Powered by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 11: World Historic Review for Powered by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2021 and % CAGR

Table 12: World 18-Year Perspective for Powered by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Passive by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 14: World Historic Review for Passive by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2021 and % CAGR

Table 15: World 18-Year Perspective for Passive by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Mobile by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 17: World Historic Review for Mobile by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$ for
Years 2012 through 2021 and % CAGR

Table 18: World 18-Year Perspective for Mobile by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Stationary by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 20: World Historic Review for Stationary by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2021 and % CAGR

Table 21: World 18-Year Perspective for Stationary by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2023 & 2030

Table 22: World Medical Exoskeleton Market Analysis of Annual
Sales in US$ for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 23: USA Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 24: USA Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 25: USA 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 26: USA Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 27: USA Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2021 and % CAGR

Table 28: USA 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 29: USA Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 30: USA Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 31: USA 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 33: Canada Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 34: Canada 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 35: Canada Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 36: Canada Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 37: Canada 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 38: Canada Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 39: Canada Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 40: Canada 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

JAPAN
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 41: Japan Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 42: Japan Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 43: Japan 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 44: Japan Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 45: Japan Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2021 and % CAGR

Table 46: Japan 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 47: Japan Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 48: Japan Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 49: Japan 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

CHINA
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 50: China Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 51: China Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 52: China 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 53: China Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 54: China Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2021 and % CAGR

Table 55: China 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 56: China Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 57: China Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 58: China 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

EUROPE
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 59: Europe Recent Past, Current & Future Analysis for
Medical Exoskeleton by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ for Years 2022 through 2030 and % CAGR

Table 60: Europe Historic Review for Medical Exoskeleton by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2021 and % CAGR

Table 61: Europe 18-Year Perspective for Medical Exoskeleton by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2023 & 2030

Table 62: Europe Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 63: Europe Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 64: Europe 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 65: Europe Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 66: Europe Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 67: Europe 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 69: Europe Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 70: Europe 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

FRANCE
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 71: France Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 72: France Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 73: France 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 74: France Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 75: France Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 76: France 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 77: France Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 78: France Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 79: France 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

GERMANY
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 80: Germany Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 81: Germany Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 82: Germany 18-Year Perspective for Medical Exoskeleton
by Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 83: Germany Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 84: Germany Historic Review for Medical Exoskeleton by
Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 85: Germany 18-Year Perspective for Medical Exoskeleton
by Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 86: Germany Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 87: Germany Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 88: Germany 18-Year Perspective for Medical Exoskeleton
by Mobility - Percentage Breakdown of Value Sales for Mobile
and Stationary for the Years 2012, 2023 & 2030

ITALY
Table 89: Italy Recent Past, Current & Future Analysis for
Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 90: Italy Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 91: Italy 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 92: Italy Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 93: Italy Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2021 and % CAGR

Table 94: Italy 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 95: Italy Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 96: Italy Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 97: Italy 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

UNITED KINGDOM
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 98: UK Recent Past, Current & Future Analysis for Medical
Exoskeleton by Component - Hardware and Software - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 99: UK Historic Review for Medical Exoskeleton by
Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 100: UK 18-Year Perspective for Medical Exoskeleton by
Component - Percentage Breakdown of Value Sales for Hardware
and Software for the Years 2012, 2023 & 2030

Table 101: UK Recent Past, Current & Future Analysis for
Medical Exoskeleton by Type - Powered and Passive - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 102: UK Historic Review for Medical Exoskeleton by Type -
Powered and Passive Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2021 and % CAGR

Table 103: UK 18-Year Perspective for Medical Exoskeleton by
Type - Percentage Breakdown of Value Sales for Powered and
Passive for the Years 2012, 2023 & 2030

Table 104: UK Recent Past, Current & Future Analysis for
Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 105: UK Historic Review for Medical Exoskeleton by
Mobility - Mobile and Stationary Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 106: UK 18-Year Perspective for Medical Exoskeleton by
Mobility - Percentage Breakdown of Value Sales for Mobile and
Stationary for the Years 2012, 2023 & 2030

REST OF EUROPE
Table 107: Rest of Europe Recent Past, Current & Future
Analysis for Medical Exoskeleton by Component - Hardware and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2022 through 2030 and % CAGR

Table 108: Rest of Europe Historic Review for Medical
Exoskeleton by Component - Hardware and Software Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2021 and % CAGR

Table 109: Rest of Europe 18-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2023 & 2030

Table 110: Rest of Europe Recent Past, Current & Future
Analysis for Medical Exoskeleton by Type - Powered and Passive -
Independent Analysis of Annual Sales in US$ for the Years
2022 through 2030 and % CAGR

Table 111: Rest of Europe Historic Review for Medical
Exoskeleton by Type - Powered and Passive Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 112: Rest of Europe 18-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2023 & 2030

Table 113: Rest of Europe Recent Past, Current & Future
Analysis for Medical Exoskeleton by Mobility - Mobile and
Stationary - Independent Analysis of Annual Sales in US$ for
the Years 2022 through 2030 and % CAGR

Table 114: Rest of Europe Historic Review for Medical
Exoskeleton by Mobility - Mobile and Stationary Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2021 and % CAGR

Table 115: Rest of Europe 18-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2023 & 2030

ASIA-PACIFIC
Medical Exoskeleton Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 116: Asia-Pacific Recent Past, Current & Future Analysis
for Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 117: Asia-Pacific Historic Review for Medical Exoskeleton
by Component - Hardware and Software Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 118: Asia-Pacific 18-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2023 & 2030

Table 119: Asia-Pacific Recent Past, Current & Future Analysis
for Medical Exoskeleton by Type - Powered and Passive -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 120: Asia-Pacific Historic Review for Medical Exoskeleton
by Type - Powered and Passive Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2021 and % CAGR

Table 121: Asia-Pacific 18-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2023 & 2030

Table 122: Asia-Pacific Recent Past, Current & Future Analysis
for Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 123: Asia-Pacific Historic Review for Medical Exoskeleton
by Mobility - Mobile and Stationary Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 124: Asia-Pacific 18-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2023 & 2030

REST OF WORLD
Table 125: Rest of World Recent Past, Current & Future Analysis
for Medical Exoskeleton by Component - Hardware and Software -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 126: Rest of World Historic Review for Medical
Exoskeleton by Component - Hardware and Software Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2021 and % CAGR

Table 127: Rest of World 18-Year Perspective for Medical
Exoskeleton by Component - Percentage Breakdown of Value Sales
for Hardware and Software for the Years 2012, 2023 & 2030

Table 128: Rest of World Recent Past, Current & Future Analysis
for Medical Exoskeleton by Type - Powered and Passive -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 129: Rest of World Historic Review for Medical
Exoskeleton by Type - Powered and Passive Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2021 and
% CAGR

Table 130: Rest of World 18-Year Perspective for Medical
Exoskeleton by Type - Percentage Breakdown of Value Sales for
Powered and Passive for the Years 2012, 2023 & 2030

Table 131: Rest of World Recent Past, Current & Future Analysis
for Medical Exoskeleton by Mobility - Mobile and Stationary -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 132: Rest of World Historic Review for Medical
Exoskeleton by Mobility - Mobile and Stationary Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2021 and % CAGR

Table 133: Rest of World 18-Year Perspective for Medical
Exoskeleton by Mobility - Percentage Breakdown of Value Sales
for Mobile and Stationary for the Years 2012, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032149/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001